Navigation Links
EnVivo Pharmaceuticals Names Stephen DiPalma Chief Financial Officer
Date:9/9/2009

WATERTOWN, Mass., Sept. 9 /PRNewswire/ -- EnVivo Pharmaceuticals today announced the appointment of Stephen J. DiPalma as senior vice president and chief financial officer. DiPalma is responsible for overall financial operations for EnVivo including financial analysis, accounting and operations.

"EnVivo has grown to the point where we have created a CFO position to help better manage our broad pipeline and increasing business opportunities," said Kees Been, CEO of EnVivo. "Steve brings a broad skill set and a proven track record to the position that combines a strategic business perspective and an entrepreneurial spirit. We anticipate his 25 years of experience to be a great asset to EnVivo at this important time for our company."

Most recently, DiPalma was Executive Vice President of Business Operations and CFO for RXi Pharmaceuticals Corporation, a company focusing on RNAi therapeutics that he helped to bring public. He was also Co-founder, President and CEO of Catalyst Oncology which focused on personalized medicine approaches for multiple forms of cancer. Prior to RXi and Catalyst Oncology, DiPalma served as CFO at companies including Milkhaus Laboratories, Phytera, Aquila Biopharmaceuticals and Athena Diagnostics.

DiPalma has an MBA, with concentrations in finance and accounting, from Babson College, and received a Bachelor of Science degree in Business Administration from the University of Massachusetts.

About EnVivo Pharmaceuticals

EnVivo Pharmaceuticals, located in Watertown, Mass., is a biopharmaceutical company dedicated to discovering and developing small molecule therapeutics for disorders of the central nervous system, with a current focus on Alzheimer's disease, Cognitive Disorders and Schizophrenia. The company's lead product
'/>"/>

SOURCE EnVivo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. EnVivo Pharmaceuticals Announces Results and Successful Completion of EVP-6124 Phase Ib/IIa Trial at the International Conference on Alzheimers Disease
2. EnVivo Pharmaceuticals Announces Reversal of Cognitive Deficits in Alzheimers Disease Transgenic Mouse Model With Gamma-Secretase Modulator
3. EnVivo Pharmaceuticals Announces Executive Appointment
4. Oramed Pharmaceuticals Commences Human Clinical Trials of an Oral GLP-1 Analog
5. Wilmington Pharmaceuticals Receives FDA Approval for Orally Disintegrating Metoclopramide Tablet
6. Lexicon Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
7. Alexza Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
8. Trubion Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Conference
9. Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program
10. Jiangbo Pharmaceuticals Reaffirms Guidance for Fiscal 2009
11. Onyx Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Oct. 30, 2014  Ardelyx, Inc. (NASDAQ: ... on cardio-renal, gastrointestinal and metabolic diseases, today announced ... results on Thursday, November 6, 2014. Following the ... live conference call and webcast at 4:30pm ET ... a business update. The live webcast ...
(Date:10/30/2014)... Texas (PRWEB) October 30, 2014 ... Naltrexone HCL Industry” is a professional and in-depth ... report provides basic Naltrexone HCL information, including its ... well as industry overview. This research covers the ... well as global industry analysis covering macroeconomic environment ...
(Date:10/30/2014)... October 30, 2014 SoundConnect ... provider, offers Office 365 end users the key ... complete phone system by adding voice enablement and ... includes Lync Online, a communication tool that includes ... With hosted voice, O365 becomes a comprehensive unified ...
(Date:10/30/2014)... MA (PRWEB) October 30, 2014 James Sherley ... advance in adult tissue stem cell technology since his days ... (FCCC) in Philadelphia in the late 1990’s. Sherley founded ... The company holds all the intellectual property developed in ... professor at the Massachusetts Institute of Technology (MIT), and more ...
Breaking Biology Technology:Ardelyx to Report Third Quarter 2014 Financial Results on November 6, 2014 2Naltrexone HCL Market & Nalbuphine HCL Industry Analysis for Global, China Regions Now at DeepResearchReports.com 2Naltrexone HCL Market & Nalbuphine HCL Industry Analysis for Global, China Regions Now at DeepResearchReports.com 3SoundConnect Launches Voice Enablement and Hybrid Audio Conferencing for Office 365 2SoundConnect Launches Voice Enablement and Hybrid Audio Conferencing for Office 365 3Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 2Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 3Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 4
... Varian, Inc.,(NasdaqGS: VARI) today announced a plan to ... to close certain facilities. , ... economic environment,we are taking proactive steps to reduce our ... while continuing to invest in new product,development and maintaining ...
... Associates, Inc.,(SullivanCotter) has published its 16th 2008 Physician ... Notable findings this year,include an average salary increase ... physicians. Nearly three-quarters (72%) of the survey,participants ... 2008,which is comparable to last year, when 73% ...
... have entered into a research collaboration to improve insect control in ... ... Research Triangle Park, NC (Vocus) January 15, 2009 -– DuPont and ... improve insect control in corn and soybeans. Under the agreement, ...
Cached Biology Technology:Varian, Inc. Announces Cost Reduction Plan 2Despite Economic Woes, Physician Compensation Increases 2Despite Economic Woes, Physician Compensation Increases 3DuPont and Athenix Collaborate to Advance Insect Control in Corn, Soybeans 2DuPont and Athenix Collaborate to Advance Insect Control in Corn, Soybeans 3
(Date:10/28/2014)... awards to expand the Office of Rare Diseases ... Translational Sciences (ORDR-NCATS) collaborative Rare Diseases Clinical Research ... at 22 consortia will work with 98 patient ... new treatments for patients with rare diseases. The ... fiscal 2014 funding from NIH. , Rett syndrome, ...
(Date:10/28/2014)... will be building a hybrid micro-grid which will ... first in the region, the hybrid micro-grid will ... tidal-current, diesel, storage and power-to-gas technologies, and ensure ... be built under the new Renewable Energy Integration ... be located offshore at Semakau Landfill and is ...
(Date:10/27/2014)... are an indigenous species of the West Antarctic Peninsula ... Earth. Since 1950, the average annual temperature in the ... and 6 degrees Celsius during winter. , As ... dry, polar system to a warmer, sub-polar system with ... a connection between local weather conditions and the weight ...
Breaking Biology News(10 mins):NIH's ORDR-NCATS RDCRN & NICHD awards U54 cooperative agreement for natural history study 2NIH's ORDR-NCATS RDCRN & NICHD awards U54 cooperative agreement for natural history study 3NTU to build region's first renewable energy integration demonstration micro-grid 2NTU to build region's first renewable energy integration demonstration micro-grid 3University of Delaware study connects penguin chick weights to local weather conditions 2University of Delaware study connects penguin chick weights to local weather conditions 3
... Human Genome Research Institute (NHGRI), one of the National ... Sequencing Research Network will target 13 more organisms as ... that will expand biological knowledge and improve human health. ... (NACHGR), which is a federally chartered committee that advises ...
... proteins have evolved, UT Southwestern Medical Center researchers have ... to use to design proteins, rules the scientists have ... function just like their natural counterparts. , In two ... journal Nature, Dr. Rama Ranganathan, associate professor of pharmacology, ...
... swat a fly? The fly's secret in avoiding death in ... to fly out of the way. "This kind of low-power ... robots", according to Gwyneth Card of the California Institute of ... response at the Society for Experimental Biology Annual Main Meeting ...
Cached Biology News:NHGRI Selects 13 More Organisms for Genome Sequencing 2NHGRI Selects 13 More Organisms for Genome Sequencing 3NHGRI Selects 13 More Organisms for Genome Sequencing 4NHGRI Selects 13 More Organisms for Genome Sequencing 5Researchers create functioning artificial proteins using nature's rules 2Researchers create functioning artificial proteins using nature's rules 3
Preparation TW--Compatibility: no end cap seals -Hybridization Tube for Hybrigene -Comp Dim: 240 80 mm -Material: borosilicate glass -Mfr Desig: Techne FHB-15...
...
... For use in hybridization incubators ... and GL 45 size PP plug-seal ... seal. Available in three lengths to ... plug-seal caps and O-rings available separately. ...
... extraction of DNA from agarose gels The SpinPrep ... of 150 bp to > 12,000 bp in size ... dissolve the gel slice, followed by adsorption of the ... format. After a wash step, the purified DNA is ...
Biology Products: